Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2

Journal Article · · Proceedings of the National Academy of Sciences of the United States of America
 [1];  [1];  [2];  [3];  [3];  [3];  [3];  [3];  [3];  [1];  [3];  [4];  [5];  [5];  [5];  [5];  [6];  [2];  [2];  [2] more »;  [2];  [3];  [3];  [3];  [5];  [4];  [2];  [6];  [3];  [3];  [3];  [3];  [3];  [2];  [1];  [7] « less
  1. Applied Biomedical Science Institute, San Diego, CA (United States)
  2. Kansas State Univ., Manhattan, KS (United States)
  3. The Scripps Research Inst., La Jolla, CA (United States)
  4. OmniAb Inc., Emeryville, CA (United States)
  5. Ligand Pharmaceuticals, San Diego, CA (United States)
  6. Univ. of Louisville, KY (United States)
  7. Applied Biomedical Science Institute, San Diego, CA (United States); The Scripps Research Inst., La Jolla, CA (United States)
Cows produce antibodies with a disulfide-bonded antigen-binding domain embedded within ultralong heavy chain third complementarity determining regions. This “knob” domain is analogous to natural cysteine-rich peptides such as knottins in that it is small and stable but can accommodate diverse loops and disulfide bonding patterns. We immunized cattle with SARS-CoV-2 spike and found ultralong CDR H3 antibodies that could neutralize several viral variants at picomolar IC50 potencies in vitro and could protect from disease in vivo. The independent CDR H3 peptide knobs were expressed and maintained the properties of the parent antibodies. The knob interaction with SARS-CoV-2 spike was revealed by electron microscopy, X-ray crystallography, NMR spectroscopy, and mass spectrometry and established ultralong CDR H3-derived knobs as the smallest known recombinant independent antigen-binding fragment. Unlike other vertebrate antibody fragments, these knobs are not reliant on the immunoglobulin domain and have potential as a new class of therapeutics.
Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS); Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States). Advanced Light Source (ALS); SLAC National Accelerator Laboratory (SLAC), Menlo Park, CA (United States). Stanford Synchrotron Radiation Lightsource (SSRL)
Sponsoring Organization:
Bill and Melinda Gates Foundation; National Institute of General Medical Sciences (NIGMS); National Institutes of Health (NIH); USDOE Office of Science (SC), Basic Energy Sciences (BES); USDOE Office of Science (SC), Biological and Environmental Research (BER)
Grant/Contract Number:
AC02-05CH11231; AC02-06CH11357; AC02-76SF00515
OSTI ID:
2423701
Journal Information:
Proceedings of the National Academy of Sciences of the United States of America, Journal Name: Proceedings of the National Academy of Sciences of the United States of America Journal Issue: 39 Vol. 120; ISSN 0027-8424
Publisher:
National Academy of SciencesCopyright Statement
Country of Publication:
United States
Language:
English

References (65)

Molecular chaperones (TrxA, SUMO, Intein, and GST) mediating expression, purification, and antimicrobial activity assays of plectasin in Escherichia coli journal January 2015
Stability of Recombinant Consensus Interferon to Air‐Jet and Ultrasonic Nebulization journal October 1995
Crystal structure of the tenth type III cell adhesion module of human fibronectin journal March 1994
The molecular surface package journal June 1993
Monoclonal antibody therapies against SARS-CoV-2 journal November 2022
Miniproteins in medicinal chemistry journal September 2022
Engineered knottin peptides as diagnostics, therapeutics, and drug delivery vehicles journal October 2016
Reshaping Antibody Diversity journal June 2013
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies journal August 2020
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology journal November 2020
The antigenic anatomy of SARS-CoV-2 receptor binding domain journal April 2021
A 45-Amino-Acid Scaffold Mined from the PDB for High-Affinity Ligand Engineering journal July 2015
Distinct antibody species: structural differences creating therapeutic opportunities journal June 2016
Speed and need: twin development challenges in rapid response for a SARS-CoV-2 antibody cocktail journal August 2022
Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins journal October 2009
In vitro and in vivo immunogenicity assessment of protein aggregate characteristics journal January 2023
Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization journal August 2018
Antibody-mediated neutralization of SARS-CoV-2 journal June 2022
50 Years of structural immunology journal January 2021
COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt? journal May 2022
Broad and ultra-potent cross-clade neutralization of HIV-1 by a vaccine-induced CD4 binding site bovine antibody journal May 2022
Immunogenicity of Therapeutic Protein Aggregates journal February 2016
Unfolding and Aggregation Pathways of Variable Domains from Immunoglobulin Light Chains journal February 2023
The Chemical Synthesis of Knob Domain Antibody Fragments journal August 2021
Cross-neutralization of influenza A viruses mediated by a single antibody loop journal September 2012
Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows journal July 2017
A human monoclonal antibody blocking SARS-CoV-2 infection journal May 2020
Human neutralizing antibodies elicited by SARS-CoV-2 infection journal May 2020
Convergent antibody responses to SARS-CoV-2 in convalescent individuals journal June 2020
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike journal July 2020
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies journal October 2020
Concurrent structural and biophysical traits link with immunoglobulin light chains amyloid propensity journal December 2017
Protein scaffolds: antibody alternatives for cancer diagnosis and therapy journal January 2022
Design of therapeutic proteins with enhanced stability journal July 2009
The Role of the Thioredoxin and Glutaredoxin Pathways in Reducing Protein Disulfide Bonds in the Escherichia coli Cytoplasm journal June 1997
Aggregation risk prediction for antibodies and its application to biotherapeutic development journal March 2015
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline journal January 2020
The proximity of the N- and C- termini of bovine knob domains enable engineering of target specificity into polypeptide chains journal May 2022
Emerging antibody-based therapeutics against SARS-CoV-2 during the global pandemic journal November 2020
CoV3D: a database of high resolution coronavirus protein structures journal September 2020
Alternative binding proteins: Anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities: Anticalins journal April 2008
Structural basis of broad HIV neutralization by a vaccine-induced cow antibody journal May 2020
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses journal May 2021
Structural mapping of antibody landscapes to human betacoronavirus spike proteins journal May 2022
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2 journal May 2020
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody journal July 2020
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability journal June 2020
Broad neutralization of SARS-related viruses by human monoclonal antibodies journal June 2020
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model journal June 2020
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail journal June 2020
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies journal June 2020
Structural basis of a shared antibody response to SARS-CoV-2 journal July 2020
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants journal August 2021
Conservation and diversity in the ultralong third heavy-chain complementarity-determining region of bovine antibodies journal June 2016
Stereotypic neutralizing V H antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals journal January 2021
Applications of Nanobodies journal February 2021
Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy journal January 2015
Isolation of antigen-specific, disulphide-rich knob domain peptides from bovine antibodies journal September 2020
Diversity in the Cow Ultralong CDR H3 Antibody Repertoire journal June 2018
Structural Diversity of Ultralong CDRH3s in Seven Bovine Antibody Heavy Chains journal March 2019
Immunogenicity Risk Assessment of Spontaneously Occurring Therapeutic Monoclonal Antibody Aggregates journal July 2022
Complete variable domain sequences of monoclonal antibody light chains identified from untargeted RNA sequencing data journal April 2023
Neutralizing Antibody Therapeutics for COVID-19 journal April 2021
Discovering drugs to treat coronavirus disease 2019 (COVID-19) journal February 2020
The allosteric modulation of complement C5 by knob domain peptides journal February 2021

Similar Records

Conservation and diversity in the ultralong third heavy-chain complementarity-determining region of bovine antibodies
Journal Article · Wed Jul 13 20:00:00 EDT 2016 · Science Immunology · OSTI ID:1368222

Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity
Journal Article · Tue Nov 24 19:00:00 EST 2020 · Immunity · OSTI ID:1816211